Lower Incidence of Chronic Allograft Nephropathy at 1 Year Post-Transplantation in Patients Treated with Mycophenolate Mofetil
Open Access
- 29 June 2004
- journal article
- clinical trial
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (11), 1769-1775
- https://doi.org/10.1111/j.1600-6143.2004.00533.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Chronic RejectionImmunity, 2001
- Strategies for Making More Organs Available for TransplantationNew England Journal of Medicine, 2000
- Chronic allograft nephropathy: An updateKidney International, 1999
- Rethinking Chronic Allograft NephropathyJournal of the American Society of Nephrology, 1999
- HISTOLOGIC FEATURES OF CHRONIC ALLOGRAFT NEPHROPATHY REVEALED BY PROTOCOL BIOPSIES IN KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1998
- Structure and Mechanism of Inosine Monophosphate Dehydrogenase in Complex with the Immunosuppressant Mycophenolic AcidCell, 1996
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995
- TREATMENT WITH RAPAMYCIN AND MYCOPHENOLIC ACID REDUCES ARTERIAL INTIMAL THICKENING PRODUCED BY MECHANICAL INJURY AND ALLOWS ENDOTHELIAL REPLACEMENTTransplantation, 1995
- Histopathological findings in well-functioning, long-term renal allograftsKidney International, 1992